Class Law poised for British Biotech action
Monday 13 January 2003
Class Law, the combative legal firm, is stepping up the pressure on British Biotech, saying it will begin legal proceedings against the company by the end of this month.
The solicitors say they have the backing of a number of institutional investors to launch an action alleging the pioneering biotech company issued misleading information to the stock market in the Nineties.
It has given investors until the end of this week to join a claim for damages, which could run into tens of millions of pounds – but British Biotech is considering ways to get Class Law to "put up or shut up" after years of false starts to a legal claim the company insists is without foundation.
British Biotech was floated on a tide of optimism that its novel drug technology would yield a lucrative treatment for cancer, and at one stage the company was worth £2bn. But the product, marimastat, failed its clinical trials. The company is now valued at just £30m.
The clinical research director, Andrew Millar, was sacked after claiming early trial results from marimastat were discouraging, and Class Law claims the company issued misleading statements about the likelihood of the treatment reaching the market.
Stephen Alexander, partner at Class Law, said several institutions had signed up to the claim for damages caused by the débâcle. "We are closing the books on 17 January. The train is leaving; investors either get on or they don't. We will then be in a position to present the particulars of the claim and try to start negotiations with the company."
British Biotech sources pointed out that last summer Class Law said it would ask for the disclosure of internal documents, but no such legal request has ever been made.
Culinary experts in The Netherlands thought it was 'fresh' and 'tasty'
- 1 Nokia no more: Microsoft drops once-ubiquitous mobile name – in favour of its Lumia brand
- 2 Renee Zellweger on plastic surgery: 'I'm living a more fulfilling life and I'm thrilled that perhaps it shows'
- 3 Jimmy Carr's controversial Oscar Pistorius joke goes too far at the Q Awards
- 4 Australian café owner sparks debate after saying 'No' to having unruly children on premises
- 5 NHS staff banned from drinking tea or coffee on the job because it looks like they're not working hard enough
Renee Zellweger on plastic surgery: 'I'm living a more fulfilling life and I'm thrilled that perhaps it shows'
Isis releases first video showing the stoning of woman accused of committing adultery as her father shouts 'don't call me Dad'
Diwali: What is the festival of lights – and how is it celebrated around the world?
Nathan Cirillo: Final pictures emerge of soldier moments before he was shot dead by Ottowa gunman
Ottawa shootings: Terror strikes Canadian capital as attacks leave one soldier and one suspect dead
Cameron is warned 'no possibility' of UK reducing immigration and that bid to bring in quota on migrant workers would be illegal
Of course, teenage girls need role models – but not like beauty vlogger Zoella
Support for EU membership 'at highest level since 1991' with most Brits wanting to stay 'in'
Residents should throw a street party and mix with immigrant neighbours, councils told
Russell Brand threatened with arrest after filming outside Fox News headquarters
London bus driver 'kicks gay couple off for kissing'
iJobs Money & Business
£350 - £360 per day: Ashdown Group: SQL Developer with T-SQL, Watford, Hertfor...
120-150k: Accountancy Action: We are looking for an experienced CFO from a min...
£24000 - £28000 per annum + bonus & benefits: Ashdown Group: IT Business Syste...
£18000 - £23000 per annum + Commission: SThree: The SThree group is a world le...